Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add filters

Database
Language
Document Type
Year range
1.
J Matern Fetal Neonatal Med ; 35(25): 8844-8847, 2022 Dec.
Article in English | MEDLINE | ID: covidwho-2250299

ABSTRACT

INTRODUCTION: The COVID-19 pandemic has made it difficult to respond to demands in maternal health around the world. Placenta accreta spectrum (PAS) is one of the most severe obstetric conditions and usually requires the use of multiple health resources We describe the clinical results of the management of PAS patients during the COVID-19 pandemic and analyze how the pandemic may affect the functioning of a PAS team. METHODOLOGY: This was a descriptive, retrospective study including all patients treated for PAS in two low- to middle-income country reference hospitals between January 2020 and March 2021. The clinical results of patients with SARS-CoV-2 infection during PAS surgery (Group 1) were compared with those of PAS patients without SARS-CoV-2 infection (Group 2). RESULTS: One hundred forty-five patients undergoing surgery for PAS were included. Group 1 patients (11 cases) showed a longer operative time (250 min, IQR 200-300) and a higher frequency of intra- or postoperative complications (54.5%) than group 2 patients (180 min [IQR 125-240], and 17.9%). CONCLUSION: Placenta accreta spectrum patients undergoing surgery during acute SARS-CoV-2 infection have a higher frequency of postoperative complications. PAS teams must prepare to modify their management protocols to minimize risks for patients and healthcare personnel.


Subject(s)
COVID-19 , Placenta Accreta , Placenta Previa , Pregnancy , Female , Humans , Placenta Accreta/epidemiology , Placenta Accreta/surgery , Retrospective Studies , Pandemics , Hysterectomy/methods , SARS-CoV-2 , Postoperative Complications/surgery , Placenta , Placenta Previa/surgery
SELECTION OF CITATIONS
SEARCH DETAIL